Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single-Ascending Dose and Multiple-Ascending Dose Trial of Adjunctive EVX-101 in Healthy Volunteers Treated With a First-Line Antidepressant - Yahoo Finance
Submitted by Anonymous (not verified) on Mon, 04/10/2023 - 11:00
